QNCX short interest
Quince Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 59,944 |
|---|---|
| Change vs prior report | 9,671 (+19.2%) |
| Change over six months | -99.6% |
| Days to cover | 2.67 (sector: 3.78) |
| Average daily volume | 22,463 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
QNCX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 59,944 | +19.2% | 2.67 | 22,463 |
| 2026-09-15 | 50,273 | -11.8% | 3.00 | 16,765 |
| 2026-08-31 | 56,989 | -5.5% | 2.66 | 21,437 |
| 2026-08-14 | 60,277 | +6.4% | 1.73 | 34,902 |
| 2026-07-31 | 56,631 | +12.0% | 1.52 | 37,331 |
| 2026-07-15 | 50,574 | -55.2% | 1.18 | 42,759 |
| 2026-06-30 | 112,788 | -94.4% | 4.78 | 23,583 |
| 2026-06-15 | 2,012,417 | -2.3% | 3.34 | 601,724 |
| 2026-05-29 | 2,059,788 | +17.2% | 1.00 | 3,488,377 |
| 2026-05-15 | 1,758,167 | -1.5% | 2.29 | 767,529 |
| 2026-04-30 | 1,784,949 | -8.6% | 1.07 | 1,660,677 |
| 2026-04-15 | 1,951,816 | -85.9% | 1.00 | 21,241,546 |
| 2026-03-31 | 13,826,556 | +24.0% | 1.00 | 27,231,626 |
| 2026-03-13 | 11,153,033 | +34.4% | 1.00 | 47,078,857 |
| 2026-02-27 | 8,298,192 | -19.7% | 1.00 | 41,372,336 |
| 2026-02-13 | 10,338,418 | +451.1% | 1.00 | 284,154,407 |
| 2026-01-30 | 1,875,868 | -45.7% | 1.00 | 6,834,214 |
| 2026-01-15 | 3,454,280 | +31.9% | 3.30 | 1,046,808 |
| 2025-12-31 | 2,617,907 | +26.8% | 5.23 | 500,623 |
| 2025-12-15 | 2,064,545 | +33.0% | 1.71 | 1,208,667 |
| 2025-11-28 | 1,551,992 | +13.6% | 1.42 | 1,095,710 |
| 2025-11-14 | 1,365,905 | +4.2% | 2.70 | 506,406 |
| 2025-10-31 | 1,311,476 | -0.9% | 6.25 | 209,883 |
| 2025-10-15 | 1,324,098 | +48.5% | 2.27 | 582,225 |
| 2025-09-30 | 891,442 | +2.1% | 3.37 | 264,232 |
import finzdata as yf
yf.Ticker("QNCX").short_interest # every report since 2017
yf.Client().short_interest(["QNCX"], start="2018-01-01")Healthcare short interest · QNCX price history · Who owns QNCX · All short interest